CJC-1295

CJC-1295 is an engineered analog of growth hormone-releasing hormone featuring four protective structural substitutions and a C-terminal bioconjugation complex designed to investigate continuous receptor agonism in preclinical models.

≥99% purity, third-party COA verified, manufactured in the USA. For research use only — not for human or veterinary use.